{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:06:42Z","timestamp":1793452002171,"version":"4.5.0"},"reference-count":306,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.dsx.2024.103098","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T13:46:30Z","timestamp":1722951990000},"page":"103098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Epidemiology of lipid disturbances in psoriasis: An analysis of trends from 2006 to 2023"],"prefix":"10.1016","volume":"18","author":[{"given":"Miao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokgyeong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naixuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2525-9679","authenticated-orcid":false,"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.dsx.2024.103098_bib2","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2147\/JIR.S441100","article-title":"Microbiome: role in inflammatory skin diseases","volume":"17","author":"Zhang","year":"2024","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.dsx.2024.103098_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fimmu.2018.00579","article-title":"Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences","volume":"9","author":"Boehncke","year":"2018","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.dsx.2024.103098_bib4","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/jdv.18296","article-title":"Global prevalence of metabolic syndrome in patients with psoriasis in the past two decades: current evidence","volume":"36","author":"Liu","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jaad.2009.09.053","article-title":"Obesity and psoriasis: from the medical board of the national psoriasis foundation","volume":"63","author":"Bremmer","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.dsx.2024.103098_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.570992","article-title":"Association between psoriasis and dementia: current evidence","volume":"12","author":"Liu","year":"2020","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"10.1016\/j.dsx.2024.103098_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145221","article-title":"Association between psoriasis and chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.dsx.2024.103098_bib8","article-title":"Updated evidence of the association between elevated serum uric acid level and psoriasis","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Med"},{"issue":"19","key":"10.1016\/j.dsx.2024.103098_bib9","doi-asserted-by":"crossref","first-page":"e3676","DOI":"10.1097\/MD.0000000000003676","article-title":"Association of serum uric acid levels in psoriasis: a systematic review and meta-analysis","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.dsx.2024.103098_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115078","article-title":"Epidemiology of mental health comorbidity in patients with psoriasis: an analysis of trends from 1986 to 2019","volume":"321","author":"Liu","year":"2023","journal-title":"Psychiatr Res"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jdv.15159","article-title":"Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study","volume":"33","author":"Fern\u00e1ndez-Armenteros","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.dsx.2024.103098_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084312","article-title":"Obesity and dyslipidemia synergistically exacerbate psoriatic skin inflammation","volume":"23","author":"Ikeda","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.dsx.2024.103098_bib13","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1016\/j.jid.2022.06.015","article-title":"Serum lipids and risk of incident psoriasis: a prospective cohort study from the UK biobank study and mendelian randomization analysis","volume":"142","author":"Xiao","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.dsx.2024.103098_bib14","article-title":"The relationship between blood lipid and risk of psoriasis: univariable and multivariable Mendelian randomization analysis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/endrev\/bnab037","article-title":"A modern approach to dyslipidemia","volume":"43","author":"Berberich","year":"2022","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/exd.13484","article-title":"High-fat diet exacerbates imiquimod-induced psoriasis-like dermatitis in mice","volume":"27","author":"Higashi","year":"2018","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2012.06.068","article-title":"Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis","volume":"224","author":"Mehta","year":"2012","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.dsx.2024.103098_bib18","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","article-title":"Psoriasis alters HDL composition and cholesterol efflux capacity","volume":"53","author":"Holzer","year":"2012","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/JID.2015.385","article-title":"Characterization of lipoprotein composition and function in pediatric psoriasis reveals a more atherogenic profile","volume":"136","author":"Tom","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"39","key":"10.1016\/j.dsx.2024.103098_bib20","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1093\/eurheartj\/ehv339","article-title":"Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis","volume":"36","author":"Salahuddin","year":"2015","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.dsx.2024.103098_bib21","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.dsx.2024.103098_bib22","first-page":"133","article-title":"Presence of comorbid psychiatric illness is associated with aortic vascular inflammation and coronary heart disease beyond traditional cardiovascular risk factors in psoriasis","author":"Aberra","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2024.103098_bib23","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/2193-1801-3-612","article-title":"Metabolic syndrome and its components in patients with psoriasis","volume":"3","author":"Albareda","year":"2014","journal-title":"SpringerPlus"},{"issue":"11\u201312","key":"10.1016\/j.dsx.2024.103098_bib24","first-page":"1247","article-title":"Psoriasis is associated with increased Framingham ten-year risk score for coronary heart disease in Tunisians","volume":"59","author":"Allal-El Asmi","year":"2013","journal-title":"Clin Lab"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.46497\/ArchRheumatol.2021.8083","article-title":"Assessment of subclinical atherosclerosis with ankle-brachial index in psoriatic arthritis: a case-control study","volume":"36","author":"Bilim","year":"2021","journal-title":"Arch Rheumatol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib26","article-title":"Frequency of metabolic syndrome and correlation with metabolic syndrome in patients with psoriatic arthritis","volume":"25","author":"Borui","year":"2021","journal-title":"Chinese J Rheumatol"},{"issue":"9","key":"10.1016\/j.dsx.2024.103098_bib27","doi-asserted-by":"crossref","first-page":"A891","DOI":"10.1016\/j.jval.2017.08.2677","article-title":"Characteristics of psoriasis patients in Latin America","volume":"20","author":"Burge","year":"2017","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/18715281113126660061","article-title":"Risk factors for cardiovascular disease in psoriasis: relation to inflammation assessed by the severity and duration of illness","volume":"12","author":"Calamita","year":"2013","journal-title":"Inflamm Allergy - Drug Targets"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib29","first-page":"63","article-title":"Failure of biologic therapy in psoriasis","volume":"40","author":"Cardona","year":"2021","journal-title":"Puert Rico Health Sci J"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib30","doi-asserted-by":"crossref","first-page":"AB260","DOI":"10.1016\/j.jaad.2016.02.1006","article-title":"Metabolic syndrome and psoriatic arthritis among Brazilian patients with plaque psoriasis-Preliminary results of the BEYOND study","volume":"74","author":"Carneiro","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib31","first-page":"AB162","article-title":"Epidemiology of childhood psoriasis: experience within a multiethnic Asian population","volume":"66","author":"Chandran","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.dsx.2024.103098_bib32","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archderm.144.12.1571","article-title":"Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome","volume":"144","author":"Chen","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.dsx.2024.103098_bib33","first-page":"136","article-title":"Psoriasis does not increase the mortality in acute myocardial infarction patients: a nationwide analysis","author":"Desai","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamadermatol.2019.3595","article-title":"Association between soluble lectinlike oxidized low-density lipoprotein receptor-1 and coronary artery disease in psoriasis","volume":"156","author":"Dey","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib35","first-page":"57","article-title":"Evaluation of chronic kidney disease and associated factors in psoriasis patients at Razi hospital, Tehran, Iran","volume":"80","author":"Dogohar","year":"2022","journal-title":"Tehran Univ Med J"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib36","first-page":"317","article-title":"Prevalence of metabolic syndrome in psoriasis patients","volume":"47","author":"Ebrahimzadeh","year":"2015","journal-title":"Kuwait Medical Journal"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib37","first-page":"877","article-title":"Subclinical atherosclerosis in psoriatic arthritis: a case-control study","volume":"35","author":"Eder","year":"2008","journal-title":"J Rheumatol"},{"issue":"SUPPL 1","key":"10.1016\/j.dsx.2024.103098_bib38","first-page":"S608","article-title":"Comorbidities among Egyptian patients with psoriatic arthritis compared to patients with psoriasis","volume":"31","author":"Eissa","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.dsx.2024.103098_bib39","first-page":"531","article-title":"Hypertension and diabetes significantly enhance the risk for cardiovascular disease in patients with psoriasic arthritis (PsA)","volume":"62","author":"Favarato","year":"2014","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib40","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s12603-012-0009-0","article-title":"Psoriasis in patients older than 65 years. A comparative study with younger adult psoriatic patients","volume":"16","author":"Fernandez-Torres","year":"2012","journal-title":"J Nutr Health Aging"},{"issue":"SUPPL 1","key":"10.1016\/j.dsx.2024.103098_bib41","first-page":"1710","article-title":"Cardiovascular comorbidities in psoriatic arthritis: a case control study","volume":"79","author":"Galarza-Delgado","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000111511","article-title":"What characterizes the severity of psoriasis? Results from an epidemiological study of over 3,300 patients in the Iberian region","volume":"216","author":"Garc\u00eda-Diez","year":"2008","journal-title":"Dermatology"},{"issue":"14","key":"10.1016\/j.dsx.2024.103098_bib43","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.dsx.2024.103098_bib44","first-page":"907","article-title":"The relationship between symptoms of autonomic dysfunction and cardiovascular involvement in psoriatic arthritis","volume":"78","author":"Gezer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.dsx.2024.103098_bib45","first-page":"1460","article-title":"Prevalence of comorbidities in psoriatic arthritis: a cross-sectional study","volume":"76","author":"Gudu","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.dsx.2024.103098_bib46","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/ijd.12196","article-title":"Psoriasis and the Framingham risk score in a Danish hospital cohort","volume":"53","author":"Gyldenl\u00f8ve","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.dsx.2024.103098_bib47","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/annrheumdis-2022-eular.1767","article-title":"INCREASED number of comorbidities and cardiovascular risk factors in early psoriatic arthritis patients suggests an intrinsic disease impact","volume":"81","author":"Ishchenko","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib48","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/ijd.12811","article-title":"High prevalence of metabolic syndrome in patients with psoriasis in Lebanon: a prospective study","volume":"55","author":"Itani","year":"2016","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.dsx.2024.103098_bib49","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-4632.2012.05517.x","article-title":"Comorbidities, metabolic risk profile and health-related quality of life in German patients with plaque-type psoriasis: a cross-sectional prospective study","volume":"52","author":"Jacobi","year":"2013","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib50","first-page":"307","article-title":"Frequency of dyslipidemia in patients with psoriasis","volume":"24","author":"Jamil","year":"2014","journal-title":"J Pak Assoc Dermatol"},{"issue":"7","key":"10.1016\/j.dsx.2024.103098_bib51","first-page":"3707","article-title":"A cross sectional study of Co-morbidities among patients with chronic plaque psoriasis at tertiary care hospital","volume":"20","author":"Jarang","year":"2022","journal-title":"NeuroQuantology"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib52","first-page":"122","article-title":"Higher incidence rates of comorbidities in patients with psoriatic arthritis compared with the general population using U.S. Administrative claims data","volume":"25","author":"Kaine","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/1346-8138.16603","article-title":"Epidemiological survey of patients with psoriatic arthritis in the Japanese Society for Psoriasis Research from 2017 to 2020","volume":"50","author":"Kamiya","year":"2023","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib54","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/1346-8138.15803","article-title":"Epidemiological survey of the psoriasis patients in the Japanese society for psoriasis research from 2013 to 2018","volume":"48","author":"Kamiya","year":"2021","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/11530640-000000000-00000","article-title":"Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial","volume":"12","author":"Kimball","year":"2011","journal-title":"Am J Clin Dermatol"},{"issue":"12","key":"10.1016\/j.dsx.2024.103098_bib56","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.53350\/pjmhs2115123430","article-title":"Frequency of dyslipidemia in patients with psoriasis and association with disease severity","volume":"15","author":"Kiran","year":"2021","journal-title":"Pakistan J Med Health Sci"},{"key":"10.1016\/j.dsx.2024.103098_bib57","first-page":"86","article-title":"Psoriasis epidemiology in a tertiary referral centre in South India","volume":"30","author":"Kirit","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.dsx.2024.103098_bib58","first-page":"A155","article-title":"The prevalence of diabetes mellitus type 2 and metabolic disorder in psoriatic arthritis patients: data of the Russian psoriatic arthritis registry (RU-psart)","volume":"21","author":"Korsakova","year":"2019","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.dsx.2024.103098_bib59","first-page":"1261","article-title":"Cardiovascular risk factors and comorbidities in patients with PSA, RA and the general population","volume":"78","author":"Landgren","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib60","first-page":"177","article-title":"Clinical profile, morbidity and outcome of adult patients with psoriasis at a district hospital in Northern Malaysia","volume":"70","author":"Loo","year":"2015","journal-title":"Med J Malaysia"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib61","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4103\/0019-5154.100474","article-title":"Prevalence of metabolic syndrome in South Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: a hospital-based case-control study","volume":"57","author":"Madanagobalane","year":"2012","journal-title":"Indian J Dermatol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib62","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/bjd.12441","article-title":"Childhood-onset psoriasis: association with future cardiovascular and metabolic comorbidities","volume":"169","author":"Mah\u00e9","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib63","first-page":"107","article-title":"A study of intima media thickness and their cardiovascular risk factors in patients with psoriatic arthritis","volume":"52","author":"Mazlan","year":"2009","journal-title":"Acta Med"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib64","first-page":"518","article-title":"Comorbidities associated with psoriasis - data from the malaysian psoriasis registry","volume":"67","author":"Mazlin","year":"2012","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.dsx.2024.103098_bib65","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1479-5876-11-194","article-title":"Modulation of cardiometabolic pathways in skin and serum from patients with psoriasis","volume":"11","author":"Mehta","year":"2013","journal-title":"J Transl Med"},{"issue":"11","key":"10.1016\/j.dsx.2024.103098_bib66","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1111\/ijd.12186","article-title":"Psoriasis and comorbidities in a southern Brazilian population: a case-control study","volume":"53","author":"Menegon","year":"2014","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib67","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/ijd.12623","article-title":"Metabolic syndrome in Moroccan patients with psoriasis","volume":"55","author":"Meziane","year":"2016","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib68","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/ijd.ijd_328_21","article-title":"The effects of acitretin on insulin resistance, glucose metabolism, and lipid levels in patients with psoriasis","volume":"67","author":"Sachdev","year":"2022","journal-title":"Indian J Dermatol"},{"issue":"suppl_1","key":"10.1016\/j.dsx.2024.103098_bib69","article-title":"Small dense high-density lipoprotein particle number relates to coronary plaque burden independent of traditional cardiovascular risk factors in psoriasis","volume":"136","author":"Sajja","year":"2017","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.dsx.2024.103098_bib70","first-page":"28","article-title":"Study of association of atherosclerotic risk factors and metabolic syndrome in patients of psoriasis at a tertiary care centre in north India: a case control study","volume":"63","author":"Sharma","year":"2015","journal-title":"J Assoc Phys India"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1346-8138.14706","article-title":"Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: quality of life and prevalence","volume":"46","author":"Souza","year":"2019","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib72","first-page":"64","article-title":"A study on co morbidities associated with psoriasis","volume":"4","author":"Vijayan","year":"2013","journal-title":"Int Res J Pharm"},{"issue":"9","key":"10.1016\/j.dsx.2024.103098_bib73","first-page":"619","article-title":"Analysis of the elevated prevalence of metabolic syndrome in patients with psoriasis","volume":"43","author":"Wu","year":"2013","journal-title":"J Wenzhou Med Univ"},{"key":"10.1016\/j.dsx.2024.103098_bib74","series-title":"Retrospective analysis of metabolic related disorders and cardiovascular risk factors in patients with psoriasis","author":"Zhang","year":"2019"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib75","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.semarthrit.2018.03.005","article-title":"Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis","volume":"48","author":"Cooksey","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib76","doi-asserted-by":"crossref","DOI":"10.1001\/archdermatol.2010.370","article-title":"Prevalence of the metabolic syndrome in psoriasis","volume":"147","author":"Love","year":"2011","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib77","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1590\/abd1806-4841.20142874","article-title":"Comorbidities and cardiovascular risk factors in patients with psoriasis","volume":"89","author":"Baeta","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.dsx.2024.103098_bib78","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2017\/24390.10348","article-title":"Association of metabolic syndrome in chronic plaque psoriasis patients and their correlation with disease severity, duration and age: a case control study from western Maharashtra","author":"Salunke","year":"2017","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib79","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1684\/ejd.2012.1714","article-title":"Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis","volume":"22","author":"Arias-Santiago","year":"2012","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib80","article-title":"Association between psoriasis vulgaris and coronary heart disease in a hospital-based population in Japan","volume":"11","author":"Taniyama","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib81","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/jdv.12595","article-title":"The association of metabolic syndrome and psoriasis: a population\u2010 and hospital\u2010based cross\u2010sectional study","volume":"29","author":"Miller","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.dsx.2024.103098_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100451","article-title":"P-88 evaluation of steatosis and liver fibrosis in patients with psoriasis: the impact of methotrexate and metabolic factors on the severity of the disease","volume":"24","author":"Agoglia","year":"2021","journal-title":"Ann Hepatol"},{"issue":"12","key":"10.1016\/j.dsx.2024.103098_bib83","first-page":"1169","article-title":"Metabolic syndrome in untreated patients with psoriasis: case\u2010control study","volume":"11","author":"Damevska","year":"2013","journal-title":"JDDG J der Deutschen Dermatol Gesellschaft"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/03009742.2019.1672783","article-title":"Cardiovascular risk factors are highly overrepresented in Swedish patients with psoriatic arthritis compared with the general population","volume":"49","author":"Landgren","year":"2019","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib85","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijwd.2019.05.003","article-title":"Sex differences in the prevalence of vascular disease and risk factors in young hospitalized patients with psoriasis","volume":"5","author":"Garshick","year":"2019","journal-title":"Int J Women's Dermatology"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib86","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaad.2010.11.046","article-title":"Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis","volume":"66","author":"Shapiro","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib87","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaad.2015.06.023","article-title":"Increased risk of arrhythmia in patients with psoriatic disease: a nationwide population-based matched cohort study","volume":"73","author":"Chiu","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib88","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00403-013-1437-3","article-title":"High prevalence of cardiovascular risk factors in patients with moderate or severe psoriasis in northern China","volume":"306","author":"Ma","year":"2014","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"10.1016\/j.dsx.2024.103098_bib89","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/1346-8138.13540","article-title":"Metabolic syndrome and psoriasis severity in South\u2010East Asian patients: an investigation of potential association using current and chronological assessments","volume":"43","author":"Chularojanamontri","year":"2016","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib90","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.15866","article-title":"Incidence of cardiovascular events among tildrakizumab\u2010treated patients with moderate\u2010to\u2010severe plaque psoriasis: pooled data from three large randomised clinical trials","volume":"34","author":"Bissonnette","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"17","key":"10.1016\/j.dsx.2024.103098_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179508","article-title":"Impact of comorbidities of patients with psoriasis on phototherapy responses","volume":"23","author":"Fat\u00e1s-Lalana","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib92","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3899\/jrheum.210159","article-title":"The association of psoriatic arthritis with all-cause mortality and leading causes of death in psoriatic arthritis","volume":"49","author":"Haddad","year":"2022","journal-title":"J Rheumatol"},{"key":"10.1016\/j.dsx.2024.103098_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2018.04.1727","article-title":"Disease burden and integreted disease management of biologic treated psoriasis patients with psoriatic arthritis in clinical practice: results from multicountry study in EU5","volume":"21","author":"Karki","year":"2018","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib94","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-017-2278-0","article-title":"Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database","volume":"17","author":"Feldman","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"10.1016\/j.dsx.2024.103098_bib95","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/jid.2013.131","article-title":"Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the rotterdam study","volume":"133","author":"Dowlatshahi","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.dsx.2024.103098_bib96","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.amjcard.2011.11.025","article-title":"Coronary artery disease in patients with psoriasis referred for coronary angiography","volume":"109","author":"Armstrong","year":"2012","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib97","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000354912","article-title":"The prevalence of systemic diseases associated with dermatoses and stroke in the United States: a cross-sectional study","volume":"227","author":"Kupetsky","year":"2013","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib98","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1468-3083.2010.03856.x","article-title":"Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants","volume":"25","author":"Mebazaa","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.dsx.2024.103098_bib99","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/jdv.15616","article-title":"Increased incidence of ischaemic heart disease and cerebrovascular disease in psoriasis patients with depression: a nationwide retrospective cohort study","volume":"33","author":"Hu","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.dsx.2024.103098_bib100","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/acr.23171","article-title":"Incidence and prevalence of cardiovascular risk factors among patients with rheumatoid arthritis, psoriasis, or psoriatic arthritis","volume":"69","author":"Radner","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib101","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1365-2133.2011.10525.x","article-title":"The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study","volume":"165","author":"Abuabara","year":"2011","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib102","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ced\/llad013","article-title":"Liver disease among patients with psoriasis: the Malaysian Psoriasis Registry","volume":"48","author":"Lim","year":"2023","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib103","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2018.5462","article-title":"Association of atherosclerosis prevalence with age, race, and traditional risk factors in patients with psoriasis","volume":"155","author":"Arnold","year":"2019","journal-title":"JAMA Dermatology"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib104","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1365-2133.2011.10494.x","article-title":"Medical comorbidity associated with psoriasis in adults: a population-based study","volume":"165","author":"Yang","year":"2011","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/24755303211021786","article-title":"Clinical characteristics and HealthCare resource utilization in patients with generalized pustular psoriasis: real-world evidence from a large claims-based dataset","volume":"6","author":"Crowley","year":"2021","journal-title":"J Psoriasis Psoriatic Arthritis"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib106","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1468-3083.2010.03730.x","article-title":"Economic burden of comorbidities in patients with psoriasis is substantial","volume":"25","author":"Kimball","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib107","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3899\/jrheum.170379","article-title":"Gaps in diagnosis and treatment of cardiovascular risk factors in patients with psoriatic disease: an international multicenter study","volume":"45","author":"Eder","year":"2018","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib108","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40266-018-0520-z","article-title":"Efficacy and safety of secukinumab in elderly subjects with moderate to severe plaque psoriasis: a pooled analysis of phase III studies","volume":"35","author":"K\u00f6rber","year":"2018","journal-title":"Drugs Aging"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib109","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5114\/dr.2022.123982","article-title":"Clinical features and comorbidities in psoriasis. A retrospective study","volume":"109","author":"Hiz \u00c7i\u00e7ekliyurt","year":"2022","journal-title":"Dermatol Rev"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1684\/ejd.2014.2291","article-title":"Cardiovascular comorbidities in childhood psoriasis","volume":"24","author":"Torres","year":"2014","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib111","doi-asserted-by":"crossref","DOI":"10.4103\/0019-5154.87144","article-title":"A study of the prevalence of diabetes, insulin resistance, lipid abnormalities, and cardiovascular risk factors in patients with chronic plaque psoriasis","volume":"56","author":"Pereira","year":"2011","journal-title":"Indian J Dermatol"},{"issue":"11","key":"10.1016\/j.dsx.2024.103098_bib112","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1468-3083.2009.03318.x","article-title":"Prevalence of myocardial infarction in patients with psoriasis in central China","volume":"23","author":"Xiao","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib113","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/jdv.13813","article-title":"Prevalence and comorbidities in adults with psoriasis compared to atopic eczema","volume":"31","author":"Radtke","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib114","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaad.2020.03.112","article-title":"Comorbidities in patients with palmoplantar plaque psoriasis","volume":"84","author":"Greenberg","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCULATIONAHA.116.026859","article-title":"Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study","volume":"136","author":"Lerman","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib116","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/00015555-0770","article-title":"Co-Morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany","volume":"90","author":"Augustin","year":"2010","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib117","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1468-3083.2011.04010.x","article-title":"Plasma and tissue osteopontin in relation to plasma selenium in patients with psoriasis","volume":"26","author":"Kadry","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.dsx.2024.103098_bib118","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s10067-019-04528-y","article-title":"Cardiac and cardiovascular morbidities in patients with psoriatic arthritis: a population-based case control study","volume":"38","author":"Kibari","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"13","key":"10.1016\/j.dsx.2024.103098_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(16)31917-9","article-title":"Small dense low-density lipoprotein (ldl) particle number predicts vascular inflammation independent of traditional lipid cardiovascular risk factors in psoriasis","volume":"67","author":"Mehta","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib120","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jhep.2009.06.008","article-title":"Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Miele","year":"2009","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib121","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1684\/ejd.2014.2346","article-title":"Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years","volume":"24","author":"Descamps","year":"2014","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169952","article-title":"The prevalence of nonalcoholic fatty liver disease and related metabolic comorbidities was associated with age at onset of moderate to severe plaque psoriasis: a cross-sectional study","volume":"12","author":"Xu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.dsx.2024.103098_bib123","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2017\/24717.9376","article-title":"Metabolic syndrome in psoriasis among urban south Indians: a case control study using SAM-NCEP criteria","author":"Girisha","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.dsx.2024.103098_bib124","article-title":"Gout augments the risk of cardiovascular disease in patients with psoriasis: a population-based cohort study","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2009.09593.x","article-title":"Epidemiology and comorbidity of psoriasis in children","volume":"162","author":"Augustin","year":"2010","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib126","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jdv.15159","article-title":"Psoriasis, metabolic syndrome and cardiovascular risk factors. A population\u2010based study","volume":"33","author":"Fern\u00e1ndez\u2010Armenteros","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib127","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/joim.13311","article-title":"Prevalence and severity of coronary artery disease linked to prognosis in psoriasis and psoriatic arthritis patients: a multi\u2010centre cohort study","volume":"290","author":"Tinggaard","year":"2021","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib128","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000544","article-title":"Associations between coronary and carotid artery atherosclerosis in patients with inflammatory joint diseases","volume":"3","author":"Svanteson","year":"2017","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib129","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/bjd.14557","article-title":"Primary care\u2010based screening for cardiovascular risk factors in patients with psoriasis","volume":"175","author":"Rutter","year":"2016","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib130","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.dsx.2024.103098_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.785719","article-title":"Increased cardiovascular risk in psoriatic arthritis: results from a case-control monocentric study","volume":"9","author":"Degbo\u00e9","year":"2022","journal-title":"Front Med"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib132","doi-asserted-by":"crossref","DOI":"10.4103\/0378-6323.72462","article-title":"Prevalence of metabolic syndrome in patients with psoriasis","volume":"76","author":"Nisa","year":"2010","journal-title":"Indian J Dermatol, Venereol Leprol"},{"key":"10.1016\/j.dsx.2024.103098_bib133","doi-asserted-by":"crossref","DOI":"10.5826\/dpc.1103a49","article-title":"Prevalence of metabolic syndrome and its parameters and their correlations with psoriasis duration, severity, and sleep quality in psoriasis patients: a cross-sectional study","author":"Tas","year":"2021","journal-title":"Dermatol Pract Concept"},{"issue":"8","key":"10.1016\/j.dsx.2024.103098_bib134","doi-asserted-by":"crossref","first-page":"775.e1","DOI":"10.1016\/j.amjmed.2011.03.028","article-title":"Attributable risk estimate of severe psoriasis on major cardiovascular events","volume":"124","author":"Mehta","year":"2011","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study","volume":"157","author":"Gisondi","year":"2007","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib136","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000111509","article-title":"Medical history, drug exposure and the risk of psoriasis","volume":"216","author":"Naldi","year":"2008","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib137","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10067-018-4004-7","article-title":"Impact of cardiovascular risk factors on the achievement of therapeutic goals in psoriatic arthritis: is there any association?","volume":"37","author":"Queiro","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.dsx.2024.103098_bib138","first-page":"102","article-title":"Traditional and non-traditional cardiovascular risk factors and cardiovascular disease in women with psoriasis","author":"N\u00e4slund-Koch","year":"2022","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.dsx.2024.103098_bib139","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ejhf.113","article-title":"Psoriasis and risk of heart failure: a nationwide cohort study","volume":"16","author":"Khalid","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00296-016-3617-x","article-title":"High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound","volume":"37","author":"Ib\u00e1\u00f1ez-Bosch","year":"2016","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib141","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaad.2010.01.050","article-title":"Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan","volume":"64","author":"Lin","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib142","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13555-022-00832-9","article-title":"Economic burden of comorbidities in patients with psoriasis in the USA","volume":"13","author":"Wu","year":"2022","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib143","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/ijd.14805","article-title":"Association of metabolic syndrome with pediatric psoriasis: a case\u2010control study in Kabul, Afghanistan","volume":"59","author":"Aalemi","year":"2020","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.dsx.2024.103098_bib144","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00403-013-1419-5","article-title":"Psoriasis, electrocardiographic characteristics, and incidence of atrial fibrillation","volume":"305","author":"Armstrong","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.dsx.2024.103098_bib145","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.18397","article-title":"Screening for comorbid cardiovascular risk factors in pediatric psoriasis among Iraqi patients: a case-control study","author":"Dhaher","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib146","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2014.2094","article-title":"Effect of psoriasis severity on hypertension control","volume":"151","author":"Takeshita","year":"2015","journal-title":"JAMA Dermatology"},{"issue":"8","key":"10.1016\/j.dsx.2024.103098_bib147","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15628","article-title":"Demographic aspects, clinical characteristics, and therapeutic approaches in geriatric psoriasis: a study from a tertiary center","volume":"35","author":"Asili","year":"2022","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib148","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2011.06.035","article-title":"Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis","volume":"67","author":"Kimball","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib149","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/jid.2009.321","article-title":"Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort","volume":"130","author":"Wakkee","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.dsx.2024.103098_bib150","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1007\/s10067-016-3362-2","article-title":"Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study","volume":"35","author":"Ahmed","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib151","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jaad.2021.09.069","article-title":"Epicardial adipose tissue volume is greater in men with severe psoriasis, implying an increased cardiovascular disease risk: a cross-sectional study","volume":"86","author":"Ellis","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib152","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/abd1806-4841.20186168","article-title":"Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis","volume":"93","author":"Ad\u0131\u015fen","year":"2018","journal-title":"An Bras Dermatol"},{"issue":"7","key":"10.1016\/j.dsx.2024.103098_bib153","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/ard.2008.094839","article-title":"Cardiovascular morbidity in psoriatic arthritis","volume":"68","author":"Gladman","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib154","doi-asserted-by":"crossref","DOI":"10.7812\/TPP\/16-073","article-title":"Incidence of pulmonary arterial hypertension in patients with psoriasis: a retrospective cohort study","volume":"21","author":"Choi","year":"2017","journal-title":"Perm J"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2230.2012.04360.x","article-title":"Modifiable lifestyle factors associated with metabolic syndrome in patients with psoriasis","volume":"37","author":"Ahdout","year":"2012","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib156","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.14496","article-title":"Risk of aortic aneurysm in patients with psoriasis: a retrospective cohort study","volume":"32","author":"No","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib157","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3899\/jrheum.150757","article-title":"Higher prevalence of metabolic syndrome in patients with psoriatic arthritis: a comparison with a control group of noninflammatory rheumatologic conditions","volume":"43","author":"Haroon","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.dsx.2024.103098_bib158","doi-asserted-by":"crossref","first-page":"194","DOI":"10.11622\/smedj.2019152","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a cross-sectional study in Singapore","author":"Chan","year":"2020","journal-title":"Singapore Medical Journal"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib159","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00296-016-3614-0","article-title":"Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study","volume":"37","author":"Nissen","year":"2016","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib160","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/jdv.12742","article-title":"Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink","volume":"29","author":"Edson\u2010Heredia","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.dsx.2024.103098_bib161","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1468-3083.2012.04706.x","article-title":"Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nation\u2010wide study","volume":"27","author":"Chin","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib162","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","article-title":"Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis","volume":"36","author":"Kimhi","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.dsx.2024.103098_bib163","doi-asserted-by":"crossref","DOI":"10.14744\/AnatolJCardiol.2016.6679","article-title":"Age and gender differences in Framingham risk score and metabolic syndrome in psoriasis patients: a cross-sectional study in the Turkish population","author":"Aksu","year":"2016","journal-title":"Anatol J Cardiol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib164","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3899\/jrheum.141359","article-title":"Comorbidities associated with psoriatic arthritis compared with non-psoriatic spondyloarthritis: a cross-sectional study","volume":"43","author":"Haque","year":"2016","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.dsx.2024.103098_bib165","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.19082\/5793","article-title":"The prevalence of cardiovascular diseases risk factors associated with psoriasis in Saudi Arabia","volume":"9","author":"Saad Alhomoud","year":"2017","journal-title":"Electron Physician"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib166","doi-asserted-by":"crossref","DOI":"10.1111\/ajd.12577","article-title":"Factors influencing cardiometabolic risk profile in patients with psoriasis","volume":"59","author":"Curc\u00f3","year":"2017","journal-title":"Australas J Dermatol"},{"issue":"18","key":"10.1016\/j.dsx.2024.103098_bib167","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016956","article-title":"Impact of psoriasis on mortality rate and outcome in myocardial infarction","volume":"9","author":"Karbach","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.dsx.2024.103098_bib168","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00296-023-05322-5","article-title":"Racial disparities in comorbidities of patients with psoriatic arthritis","volume":"43","author":"Ross","year":"2023","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib169","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jdv.16099","article-title":"Bodyweight variability and the risk of psoriasis: a nationwide population\u2010based cohort study","volume":"34","author":"Kim","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib170","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/jdv.12385","article-title":"\u2018Short\u2010term treatment with methotrexate does not affect microvascular endothelial function in patients with psoriasis\u2019","volume":"29","author":"Gyldenl\u00f8ve","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib171","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/met.2019.0092","article-title":"Prevalence of metabolic syndrome among patients with psoriasis treated with TNF inhibitors and the effects of anti-TNF therapy on their lipid profile: a prospective cohort study","volume":"18","author":"Botelho","year":"2020","journal-title":"Metab Syndr Relat Disord"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib172","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/13696998.2018.1431921","article-title":"Comorbidity and economic burden among moderate-to-severe psoriasis and\/or psoriatic arthritis patients in the US Department of Defense population","volume":"21","author":"Lee","year":"2018","journal-title":"J Med Econ"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib173","doi-asserted-by":"crossref","DOI":"10.4103\/0378-6323.183638","article-title":"Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: a hospital-based cross-sectional study","volume":"82","author":"Khanna","year":"2016","journal-title":"Indian J Dermatol, Venereol Leprol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib174","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00296-017-3895-y","article-title":"Addressing comorbidities in psoriatic disease","volume":"38","author":"Patel","year":"2017","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib175","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jdv.16566","article-title":"Epidemiologic study in a real\u2010world analysis of patients with treatment for psoriasis in the French national health insurance database","volume":"35","author":"Grodner","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib176","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/acr.23094","article-title":"Incidence and management of cardiovascular risk factors in psoriatic arthritis and rheumatoid arthritis: a population\u2010based study","volume":"69","author":"Jafri","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"10","key":"10.1016\/j.dsx.2024.103098_bib177","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/1346-8138.15052","article-title":"Increased risk of atherosclerotic cardiovascular disease among patients with psoriasis in Korea: a 15\u2010year nationwide population\u2010based cohort study","volume":"46","author":"Jung","year":"2019","journal-title":"J Dermatol"},{"issue":"31","key":"10.1016\/j.dsx.2024.103098_bib178","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016323","article-title":"Obesity and dyslipidemia in patients with psoriasis","volume":"98","author":"Miao","year":"2019","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib179","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaad.2017.06.028","article-title":"The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events","volume":"77","author":"Egeberg","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib180","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/ijd.13543","article-title":"Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries","volume":"56","author":"Kojanova","year":"2017","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib181","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.dsx.2016.01.033","article-title":"Prevalence of metabolic syndrome as per the NCEP and IDF definitions vis-a-vis severity and duration of psoriasis in a semi-urban Maharashtrian population: a case control study","volume":"10","author":"Sharma","year":"2016","journal-title":"Diabetes Metabol Syndr: Clin Res Rev"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib182","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/1346-8138.13761","article-title":"Epidemiology and cardiovascular comorbidities in patients with psoriasis: a Korean nationwide population\u2010based cohort study","volume":"44","author":"Oh","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.dsx.2024.103098_bib183","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdin.2022.04.007","article-title":"Association between psoriasis and short-term outcomes of acute myocardial infarction: a matched-pair cohort study using a nationwide inpatient database in Japan","volume":"8","author":"Miyachi","year":"2022","journal-title":"JAAD International"},{"issue":"10","key":"10.1016\/j.dsx.2024.103098_bib184","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/1346-8138.12614","article-title":"Prevalence and characteristics of metabolic syndrome in South\u2010East Asian psoriatic patients: a case\u2013control study","volume":"41","author":"Kokpol","year":"2014","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib185","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ad.2014.08.002","article-title":"Psoriasis and ischemic coronary artery disease","volume":"106","author":"Mahiques-Santos","year":"2015","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"10.1016\/j.dsx.2024.103098_bib186","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2016.05.043","article-title":"Self-reported depression in psoriasis is associated with subclinical vascular diseases","volume":"251","author":"Aberra","year":"2016","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib187","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/1346-8138.13157","article-title":"Effect of a family history of psoriasis and age on comorbidities and quality of life in patients with moderate to severe psoriasis: results from the Arizona study","volume":"43","author":"L\u00f3pez\u2010Estebaranz","year":"2015","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib188","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/ajd.13175","article-title":"Prevalence of non\u2010alcoholic fatty liver and liver fibrosis in patients with moderate\u2013severe psoriasis: a cross\u2010sectional cohort study","volume":"61","author":"Magdaleno\u2010Tapial","year":"2019","journal-title":"Australas J Dermatol"},{"issue":"8","key":"10.1016\/j.dsx.2024.103098_bib189","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/exd.14770","article-title":"Pustular psoriasis in Malaysia: a review of the Malaysian psoriasis registry 2007\u20132018","volume":"32","author":"Teoh","year":"2023","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.dsx.2024.103098_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.890195","article-title":"Prevalence and predictors of abdominal aorta calcification in patients with psoriasis\u2014a case control study","volume":"9","author":"Ramos","year":"2022","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib191","first-page":"491","article-title":"Depression and anxiety among patients with psoriasis: a correlation with quality of life and associated factors","volume":"16","author":"Bakar","year":"2021","journal-title":"J Taibah Univ Med Sci"},{"issue":"12","key":"10.1016\/j.dsx.2024.103098_bib192","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1468-3083.2012.04618.x","article-title":"Psoriasis and cardiovascular risk. Assessment by different cardiovascular risk scores","volume":"27","author":"Fern\u00e1ndez\u2010Torres","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.dsx.2024.103098_bib193","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/jdv.13700","article-title":"Prevalence of psoriatic arthritis and its correlates among patients with psoriasis in Greece: results from a large retrospective study","volume":"30","author":"Papadavid","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib194","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006450","article-title":"Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database","volume":"5","author":"Kubota","year":"2015","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.dsx.2024.103098_bib195","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10067-014-2743-7","article-title":"Prevalence of cardiovascular risk factors in patients with psoriatic arthritis","volume":"33","author":"Khraishi","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib196","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/annrheumdis-2012-201497","article-title":"The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone","volume":"72","author":"Eder","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib197","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1590\/abd1806-4841.20164716","article-title":"Diagnosis and underdiagnosis of comorbidities in psoriasis patients - need for a multidisciplinary approach","volume":"91","author":"Duarte","year":"2016","journal-title":"An Bras Dermatol"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib198","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5114\/reum.2021.112238","article-title":"Psoriatic arthritis among Egyptian patients with psoriasis attending the dermatology clinic: prevalence, comorbidities, and clinical predictors","volume":"59","author":"El-Garf","year":"2021","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib199","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/1756-185X.13421","article-title":"Polyarticular evolution and late\u2010onset psoriasis may be associated with cardiovascular disease in psoriatic arthritis","volume":"22","author":"Queiro","year":"2018","journal-title":"Int J Rheumatic Diseases"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib200","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/rheumatology\/kew502","article-title":"Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis","volume":"56","author":"Ogdie","year":"2017","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib201","doi-asserted-by":"crossref","DOI":"10.4103\/ijabmr.IJABMR_330_16","article-title":"Prevalence of metabolic syndrome in psoriasis and levels of Interleukin-6 and tumor necrosis factor-\u03b1 in psoriasis patients with metabolic syndrome: Indian Tertiary Care Hospital study","volume":"7","author":"Singh","year":"2017","journal-title":"Int J Appl Basic Med Res"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib202","doi-asserted-by":"crossref","DOI":"10.1186\/s41927-018-0034-7","article-title":"Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry","volume":"2","author":"Kavanaugh","year":"2018","journal-title":"BMC Rheumatology"},{"issue":"12","key":"10.1016\/j.dsx.2024.103098_bib203","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3899\/jrheum.160070","article-title":"Disease activity and increased risk of cardiovascular death among patients with psoriatic arthritis","volume":"43","author":"Juneblad","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.dsx.2024.103098_bib204","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2016\/17791.7218","article-title":"Prevalence of metabolic syndrome in psoriasis patients and its relation to disease duration: a hospital based case-control study","author":"Praveenkumar","year":"2016","journal-title":"J Clin Diagn Res"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib205","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2340\/00015555-0510","article-title":"Psoriasis and dyslipidaemia: a population-based study","volume":"88","author":"Dreiher","year":"2008","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib206","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.dsx.2024.103098_bib207","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ad.2017.04.015","article-title":"Cardiovascular risk factors and carotid intima-media thickness in a Colombian population with psoriasis","volume":"108","author":"Argote","year":"2017","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib208","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4274\/turkderm.galenos.2018.82085","article-title":"A cross-sectional study investigating association of liver diseases in moderate to severe psoriasis patients","volume":"53","author":"Do\u011fan","year":"2019","journal-title":"Turkderm"},{"issue":"8","key":"10.1016\/j.dsx.2024.103098_bib209","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/jdv.12232","article-title":"Psoriasis and dyslipidemia: a population\u2010based study analyzing the national health and nutrition examination survey (NHANES)","volume":"28","author":"Ma","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.dsx.2024.103098_bib210","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20976975","article-title":"Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus","volume":"12","author":"Fragoulis","year":"2020","journal-title":"Therapeutic Advances in Musculoskeletal Disease"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib211","article-title":"Pharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registries","volume":"7","author":"Zuffi","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.dsx.2024.103098_bib212","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/jid.2015.87","article-title":"Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink","volume":"135","author":"Parisi","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.dsx.2024.103098_bib213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4371471","article-title":"Epidemiology and clinical features of adult patients with psoriasis in Malaysia: 10-year review from the Malaysian psoriasis registry (2007\u20132016)","volume":"2018","author":"Mohd Affandi","year":"2018","journal-title":"Dermatology Research and Practice"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib214","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000121333","article-title":"Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001\u20132002","volume":"217","author":"Kimball","year":"2008","journal-title":"Dermatology"},{"issue":"12","key":"10.1016\/j.dsx.2024.103098_bib215","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/1346-8138.14654","article-title":"Psoriasis is associated with a greater risk for cardiovascular procedure and surgery in patients with hypertension: a nationwide cohort study","volume":"45","author":"Chiu","year":"2018","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib216","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00296-019-04461-y","article-title":"Prevalence of high-sensitivity cardiac troponin T in real-life cohorts of psoriatic arthritis and general population: a cross-sectional study","volume":"40","author":"Furer","year":"2019","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib217","article-title":"Subclinical atherosclerosis in psoriasis. Usefulness of femoral artery ultrasound for the diagnosis, and analysis of its relationship with insulin resistance","volume":"14","author":"Kirchmair","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib218","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1590\/abd1806-4841.20186397","article-title":"Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study","volume":"93","author":"Paschoal","year":"2018","journal-title":"An Bras Dermatol"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib219","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/13548506.2020.1831557","article-title":"Sexual difficulties and associated factors among patients with psoriasis in Malaysia: data from the Malaysian Psoriasis registry","volume":"27","author":"Kwan","year":"2020","journal-title":"Psychol Health Med"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib220","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/09546634.2014.952609","article-title":"Risk of myocardial infarction in psoriasis patients: a retrospective cohort study","volume":"26","author":"Wu","year":"2014","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.dsx.2024.103098_bib221","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2019.34.205.12883","article-title":"Addictive behaviors, cardiovascular and metabolic comorbidities in North African psoriatic patients: case-control study","volume":"34","author":"Aounallah","year":"2019","journal-title":"Pan African Med J"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib222","article-title":"Psoriasis and comorbidities: general practitioners' awarenes","volume":"27","author":"Costa-Silva","year":"2018","journal-title":"Acta Dermatovenerol Alpina Pannonica Adriatica"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib223","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jdermsci.2011.03.002","article-title":"Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan","volume":"63","author":"Tsai","year":"2011","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib224","doi-asserted-by":"crossref","DOI":"10.37506\/v11\/i1\/2020\/ijphrd\/194081","article-title":"Re-evaluation of psoriatic patients with metabolic syndrome:A case control study searching for the highly prevalent criteria","volume":"11","author":"Kattoof","year":"2020","journal-title":"Indian J Public Health Res Dev"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib225","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jaad.2019.10.060","article-title":"Application of machine learning to determine top predictors of noncalcified coronary burden in psoriasis: an observational cohort study","volume":"83","author":"Munger","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.dsx.2024.103098_bib226","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1468-3083.2009.03537.x","article-title":"Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population\u2010based sample","volume":"24","author":"Schmitt","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"23","key":"10.1016\/j.dsx.2024.103098_bib227","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/heartjnl-2017-311214","article-title":"Cardiovascular and type 2 diabetes morbidity and all-cause mortality among diverse chronic inflammatory disorders","volume":"103","author":"Dregan","year":"2017","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib228","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2310\/7750.2013.13052","article-title":"Risk of myocardial infarction in Canadian patients with psoriasis: a retrospective cohort study","volume":"17","author":"Levesque","year":"2013","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib229","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1346-8138.2009.00777.x","article-title":"Comorbidities associated with psoriasis: an experience from the Middle East","volume":"37","author":"Al\u2010Mutairi","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.dsx.2024.103098_bib230","doi-asserted-by":"crossref","DOI":"10.5935\/abc.20190123","article-title":"Cardiovascular risk in psoriasis patients: clinical, functional and morphological parameters","author":"Oliveira","year":"2019","journal-title":"Arq Bras Cardiol"},{"issue":"7","key":"10.1016\/j.dsx.2024.103098_bib231","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2340\/00015555-2657","article-title":"Risk of myocardial infarction in patients with psoriasis and psoriatic arthritis: a nationwide cohort study","volume":"97","author":"Egeberg","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib232","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000328397","article-title":"Patients with psoriasis have a higher prevalence of parental cardiovascular disease","volume":"222","author":"Gisondi","year":"2011","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib233","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1590\/1806-9282.64.04.368","article-title":"Metabolic syndrome and psoriasis: a study in 97 patients","volume":"64","author":"Ferdinando","year":"2018","journal-title":"Rev Assoc M\u00e9d Bras"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib234","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/ard.2010.136499","article-title":"Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis","volume":"70","author":"Jamnitski","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib235","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/abd1806-4841.20175178","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study","volume":"92","author":"Mil\u010di\u0107","year":"2017","journal-title":"An Bras Dermatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib236","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/key286","article-title":"Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study","volume":"58","author":"Charlton","year":"2019","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.dsx.2024.103098_bib237","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ad.2022.04.013","article-title":"Performance of coronary artery calcium testing in patients with severe psoriasis: risk assessment and reclassification potential in a low cardiovascular risk population","volume":"113","author":"Martinez-Domenech","year":"2022","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"issue":"10","key":"10.1016\/j.dsx.2024.103098_bib238","doi-asserted-by":"crossref","DOI":"10.5070\/D32410041706","article-title":"Incidence rates of comorbidities among patients with psoriasis in the United States","volume":"24","author":"Feldman","year":"2018","journal-title":"Dermatol Online J"},{"issue":"11","key":"10.1016\/j.dsx.2024.103098_bib239","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/jdv.12028","article-title":"Co\u2010morbidities in psoriasis: a hospital\u2010based case\u2010control study","volume":"27","author":"Tseng","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.dsx.2024.103098_bib240","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/1346-8138.14900","article-title":"Prevalence of inflammatory bowel disease in Japanese psoriatic patients","volume":"46","author":"Masaki","year":"2019","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib241","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/09546634.2014.983039","article-title":"Metabolic syndrome in Spanish patients with psoriasis needing systemic therapy: prevalence and association with cardiovascular disease in PSO-RISK, a cross-sectional study","volume":"26","author":"Belinch\u00f3n","year":"2014","journal-title":"J Dermatol Treat"},{"issue":"11","key":"10.1016\/j.dsx.2024.103098_bib242","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2298\/VSP150114138R","article-title":"Prevalence of metabolic syndrome in Montenegrin patients with psoriasis","volume":"73","author":"Raznatovic-Djurovic","year":"2016","journal-title":"Vojnosanit Pregl"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib243","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.22185","article-title":"Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis","volume":"66","author":"Labitigan","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib244","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaad.2016.06.002","article-title":"Increased risk of aortic aneurysm (AA) in relation to the severity of psoriasis: a national population-based matched-cohort study","volume":"75","author":"Chiu","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib245","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001568","article-title":"Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden","volume":"7","author":"Landgren","year":"2021","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib246","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/09546630802225702","article-title":"Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies","volume":"20","author":"Driessen","year":"2009","journal-title":"J Dermatol Treat"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib247","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s40257-021-00600-z","article-title":"Psoriasis severity and cardiometabolic risk factors in a representative US national study","volume":"22","author":"Lin","year":"2021","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib248","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2340\/00015555-3090","article-title":"Psoriasis as a predictor of cardiometabolic comorbidity in women: a study based on the Danish national birth cohort","volume":"99","author":"Blegvad","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"26","key":"10.1016\/j.dsx.2024.103098_bib249","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007308","article-title":"Cardiovascular disease in immune-mediated inflammatory diseases","volume":"96","author":"Fern\u00e1ndez-Guti\u00e9rrez","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.dsx.2024.103098_bib250","article-title":"A clinical and epidemiological study of psoriasis and its association with various biochemical parameters in newly diagnosed cases","year":"2013","journal-title":"J Clin Diagn Res"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib251","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1468-3083.2011.04108.x","article-title":"Psoriasis and hypertension: a case\u2010control study","volume":"26","author":"Armesto","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Supplement","key":"10.1016\/j.dsx.2024.103098_bib252","doi-asserted-by":"crossref","first-page":"S05","DOI":"10.21101\/cejph.a6806","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"30","author":"Kampe","year":"2022","journal-title":"Cent Eur J Publ Health"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib253","doi-asserted-by":"crossref","DOI":"10.5021\/ad.2010.22.3.300","article-title":"Association between psoriasis and cardiovascular risk factors in Korean patients","volume":"22","author":"Choi","year":"2010","journal-title":"Ann Dermatol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib254","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/jdv.12071","article-title":"A cross\u2010sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis","volume":"28","author":"Bostoen","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib255","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5152\/eurjrheum.2019.19029","article-title":"Are there any differences among psoriasis, psoriatic arthritis and rheumatoid arthritis in terms of metabolic syndrome and cardiovascular risk factors?","volume":"6","author":"Ozkul","year":"2019","journal-title":"European J Rheumatology"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib256","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/RHU.0000000000000721","article-title":"Increased prevalence of metabolic syndrome and adipocytokine levels in a psoriatic arthritis cohort","volume":"24","author":"Feld","year":"2018","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib257","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jdi.12663","article-title":"Prevalence of metabolic syndrome in Chinese psoriasis patients: a hospital\u2010based cross\u2010sectional study","volume":"9","author":"Gui","year":"2017","journal-title":"J Diabetes Investigation"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib258","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/acr.22492","article-title":"Economic and comorbidity burden among moderate\u2010to\u2010severe psoriasis patients with comorbid psoriatic arthritis","volume":"67","author":"Feldman","year":"2015","journal-title":"Arthritis Care Res"},{"issue":"12","key":"10.1016\/j.dsx.2024.103098_bib259","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/acr.20627","article-title":"Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis","volume":"63","author":"Husted","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"11","key":"10.1016\/j.dsx.2024.103098_bib260","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(18)32401-X","article-title":"The impact of cardiovascular disease risk factors on atherosclerosis in psoriasis","volume":"71","author":"Seth Garshick","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib261","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jrsm.1547","article-title":"Meta-analysis of prevalence: I(2) statistic and how to deal with heterogeneity","volume":"13","author":"Migliavaca","year":"2022","journal-title":"Res Synth Methods"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib262","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MAJ.0b013e3181ff8eeb","article-title":"Clinical improvement in psoriasis with treatment of associated hyperlipidemia","volume":"341","author":"Ghazizadeh","year":"2011","journal-title":"Am J Med Sci"},{"issue":"12","key":"10.1016\/j.dsx.2024.103098_bib263","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126561","article-title":"Aberrations in lipid expression and metabolism in psoriasis","volume":"22","author":"Nowowiejska","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib264","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12916-021-01929-2","article-title":"Sex differences in systemic metabolites at four life stages: cohort study with repeated metabolomics","volume":"19","author":"Bell","year":"2021","journal-title":"BMC Med"},{"issue":"19","key":"10.1016\/j.dsx.2024.103098_bib265","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.968792","article-title":"Sex\/gender differences in cardiovascular disease prevention: what a difference a decade makes","volume":"124","author":"Mosca","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2024.103098_bib266","article-title":"Determinants of dyslipidemia in Africa: a systematic review and meta-analysis","volume":"8","author":"Obsa","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib267","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1684\/ejd.2012.1714","article-title":"Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis","volume":"22","author":"Arias-Santiago","year":"2012","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.dsx.2024.103098_bib268","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2015.00001","article-title":"Management of moderate to severe psoriasis in patients with metabolic comorbidities","volume":"2","author":"Gisondi","year":"2015","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib269","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaad.2005.11.1079","article-title":"Psoriasis is associated with lipid abnormalities at the onset of skin disease","volume":"54","author":"Mallbris","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.dsx.2024.103098_bib270","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/jid.2010.36","article-title":"Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models","volume":"130","author":"Gudjonsson","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib271","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41467-017-00380-3","article-title":"JunB promotes Th17 cell identity and restrains alternative CD4(+) T-cell programs during inflammation","volume":"8","author":"Carr","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib272","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/cei.12017","article-title":"Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients","volume":"171","author":"Pesce","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.dsx.2024.103098_bib273","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm.3704","article-title":"De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells","volume":"20","author":"Berod","year":"2014","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.dsx.2024.103098_bib274","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nchembio.1714","article-title":"Sterol metabolism controls T(H)17 differentiation by generating endogenous ROR\u03b3 agonists","volume":"11","author":"Hu","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"11","key":"10.1016\/j.dsx.2024.103098_bib275","first-page":"747","article-title":"Cellular and molecular links between autoimmunity and lipid metabolism","volume":"42","author":"Ryu","year":"2019","journal-title":"Mol Cell"},{"issue":"11","key":"10.1016\/j.dsx.2024.103098_bib276","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1042\/CS20201394","article-title":"Cholesterol metabolism: a new molecular switch to control inflammation","volume":"135","author":"Cardoso","year":"2021","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib277","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2017.08.009","article-title":"Foundations of immunometabolism and implications for metabolic health and disease","volume":"47","author":"Hotamisligil","year":"2017","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib278","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MOL.0000000000000333","article-title":"Effect of inflammation on HDL structure and function","volume":"27","author":"Feingold","year":"2016","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib279","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.arcmed.2012.10.009","article-title":"Apolipoprotein E gene polymorphism in psoriasis: a meta-analysis","volume":"44","author":"Han","year":"2013","journal-title":"Arch Med Res"},{"key":"10.1016\/j.dsx.2024.103098_bib280","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1479-5876-11-194","article-title":"Modulation of cardiometabolic pathways in skin and serum from patients with psoriasis","volume":"11","author":"Mehta","year":"2013","journal-title":"J Transl Med"},{"key":"10.1016\/j.dsx.2024.103098_bib281","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2020.10.006","article-title":"Interaction between high-density lipoproteins and inflammation: function matters more than concentration","volume":"159","author":"Nazir","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib282","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pharmthera.2012.12.001","article-title":"Inflammation alters HDL composition and function: implications for HDL-raising therapies","volume":"137","author":"Marsche","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib283","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.atherosclerosis.2012.07.029","article-title":"HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells","volume":"225","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib284","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2133.2012.11170.x","article-title":"Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis","volume":"167","author":"Asefi","year":"2012","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.dsx.2024.103098_bib285","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jid.2018.03.1522","article-title":"High-fat diet exacerbates early psoriatic skin inflammation independent of obesity: saturated fatty acids as key players","volume":"138","author":"Herbert","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib286","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030859","article-title":"The roles of lipoprotein in psoriasis","volume":"21","author":"Shih","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.dsx.2024.103098_bib287","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.amjcard.2016.05.060","article-title":"Lipoprotein metabolism and inflammation in patients with psoriasis","volume":"118","author":"Armstrong","year":"2016","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.dsx.2024.103098_bib288","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/exd.12483","article-title":"Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function","volume":"23","author":"Marsche","year":"2014","journal-title":"Exp Dermatol"},{"issue":"7","key":"10.1016\/j.dsx.2024.103098_bib289","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.dsx.2024.103098_bib290","series-title":"MDText.com, Inc. Copyright \u00a9 2000-2024","article-title":"The effect of inflammation and infection on lipids and lipoproteins","author":"Feingold","year":"2000"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib291","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/annrheumdis-2013-203755","article-title":"Free fatty acids: potential proinflammatory mediators in rheumatic diseases","volume":"74","author":"Frommer","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib292","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1684\/ejd.2011.1467","article-title":"Cardiovascular and metabolic risk profile in German patients with moderate and severe psoriasis: a case control study","volume":"21","author":"Warnecke","year":"2011","journal-title":"Eur J Dermatol"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib293","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0190-9622(89)70138-9","article-title":"Side-effect profile of acitretin therapy in psoriasis","volume":"20","author":"Gupta","year":"1989","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.dsx.2024.103098_bib294","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM199101313240501","article-title":"Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial","volume":"324","author":"Ellis","year":"1991","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib295","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaad.2018.02.074","article-title":"Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: results from UNCOVER-1, UNCOVER-2, and UNCOVER-3","volume":"79","author":"Egeberg","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib296","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jid.2019.07.679","article-title":"A phase IV, randomized, double-blind, placebo-controlled crossover study of the effects of ustekinumab on vascular inflammation in psoriasis (the VIP-U trial)","volume":"140","author":"Gelfand","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib297","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/jdv.16004","article-title":"Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients","volume":"34","author":"Gerdes","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.dsx.2024.103098_bib298","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007394","article-title":"Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: a randomized placebo-controlled trial","volume":"11","author":"Mehta","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.dsx.2024.103098_bib299","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/j.1468-3083.2012.04450.x","article-title":"Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry","volume":"27","author":"Gisondi","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.dsx.2024.103098_bib300","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1354593","article-title":"Effects of tumor necrosis factor-alpha inhibitors on lipid profiles in patients with psoriasis: a systematic review and meta-analysis","volume":"15","author":"Su","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.dsx.2024.103098_bib301","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1741-7015-9-4","article-title":"Blood lipid profiles and peripheral blood mononuclear cell cholesterol metabolism gene expression in patients with and without methotrexate treatment","volume":"9","author":"Chen","year":"2011","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.dsx.2024.103098_bib302","first-page":"1997","article-title":"Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritis","volume":"34","author":"Saiki","year":"2007","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib303","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00296-020-04756-5","article-title":"Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trial","volume":"41","author":"Ma\u0161i\u0107","year":"2021","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.dsx.2024.103098_bib304","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0002-9343(87)90762-5","article-title":"Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids","volume":"83","author":"Ettinger","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.dsx.2024.103098_bib305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/OARRR.S245662","article-title":"Correlation between steroid therapy and lipid profile in systemic lupus erythematosus patients","volume":"12","author":"Atik","year":"2020","journal-title":"Open Access Rheumatol"},{"issue":"8","key":"10.1016\/j.dsx.2024.103098_bib306","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/apt.16580","article-title":"Systematic review with meta-analysis: effect of inflammatory bowel disease therapy on lipid levels","volume":"54","author":"Sleutjes","year":"2021","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124001590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124001590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T07:30:04Z","timestamp":1731310204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402124001590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":306,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1871402124001590"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2024.103098","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of lipid disturbances in psoriasis: An analysis of trends from 2006 to 2023","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2024.103098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103098"}}